Для наиболее комфортного просмотра сайта, включите, пожалуйста, JavaScript в настройках браузера

Противовирусный препарат Кагоцел и новый коронавирус SARS-CoV-2 (COVID-19)

News

Kagocel Ranked No. 1 OTC Drug, Showed Greatest Impact on the Pharma Market in 2016

The Romir holding elaborated a 2016 influence rating for the pharmaceutical market based on the results of an expert survey, and then, in cooperation with the KPMG consulting company, determined winners in each nomination.

Detail

Moscow European Figure Skating Championships Comes to a Triumphant Finale

The European championship on figure skating came to an end in Moscow, whereas Russia has become the undisputed leader in terms of medals won.

Detail

Health Ministry of Moldova Publishes Flu and ARVI Treatment Protocols

Flu and ARVI treatment protocols have been published on the official website of the Ministry of Health of the Republic of Moldova.

Detail

OUR AWARDS

Russia's No. 1 antiviral remedy against influenza and ARVI, according to Smartpharma Awards 2021
Antiviral agent №1 against influenza and SARS in adults and children from 3 years. Russian Pharma Awards 2020
Russia's No. 1 antiviral remedy against influenza and ARVI, according to Smartpharma Awards 2020
Russian brand No.1 in the retail market National Pharmaceutical Rating 2019
Russia's No. 1 antiviral remedy against influenza and ARVI, according to Smartpharma Awards 2019
Brand Kagocel's Initiatives Praised by Best Social Projects of Russia Program
№1 in Belarus
Antiviral agent No.1 against influenza and SARS in adults and children from 3 years Russian. Pharma Awards 2019
Russian brand No.1 in the retail market National Pharmaceutical Rating 2018
Product of the Year 2018 in the «Antimicrobials for systemic use» category
«Pharma Awards 2018» - The most often prescribed drug for the treatment of SARS and influenza
No. 1 in the nomination "Medication of choice for prophylaxis and treatment of ARVI and influenza"
No. 1 as rated by the Pharmaceutical Herald in 2017
No. 1 OTC Drug
National Pharmaceutical Rating 2017
«Pharma Awards 2017» - The most often prescribed drug in the prevention and treatment of SARS and influenza
Product of the Year 2017 in the «Antimicrobials for systemic use» category
No. 1 as rated by the Pharmaceutical Herald
«Pharma Awards 2016» -
The most often prescribed drug in the prevention and treatment of SARS and influenza
No. 1 as rated by Pharmaceutical Herald
«Russian Pharma Awards 2015» No. 1 for the prevention and treatment of SARS
«Russian Pharma Awards 2014» No. 1 for the prevention and treatment of SARS
«Green Mark» The drug of the year
Platinum ounce 2013 «The drug of the year», «Dynamics of the year»
Brand of the Year 2012 / EFFIE «Brand of the Year 2012»
People's Prize «Mark No. 1 in Russia-2012»
Platinum ounce 2012 «The drug of the year», «Dynamics of the year»
Platinum ounce 2011 «The drug of the year», «Dynamics of the year»
Brand of the Year 2011 / EFFIE «Brand of the Year 2011»